ReleaseWire

NASDAQ:UTHR Shareholder Alert: Investigation over Potential Wrongdoing by United Therapeutics Corporation

An investigation on behalf of investors in United Therapeutics Corporation (NASDAQ:UTHR) shares over potential wrongdoing at United Therapeutics was announced.

Posted: Wednesday, March 07, 2018 at 11:30 AM CST

San Diego, CA -- (SBWire) -- 03/07/2018 --An investigation was announced for investors in shares of United Therapeutics Corporation (NASDAQ:UTHR) concerning potential breaches of fiduciary duties by certain officers and directors at United Therapeutics.

Investors who purchased shares of United Therapeutics Corporation (NASDAQ:UTHR) and currently hold any of those NASDAQ:UTHR shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain United Therapeutics officers and directors breached their fiduciary duties.

United Therapeutics Corporation reported that its annual Total Revenue rose from over $1.28 billion in 2014 to over $1.46 billion in 2015 and that its Net Income increased from $340.07 million in 2014 to $651.64 million in 2015.

Shares of United Therapeutics Corporation (NASDAQ:UTHR) declined from as high as $188.15 per share in June 2015 to as low as $98.33 per share in June 27, 2016.

Those who purchased shares of United Therapeutics Corporation (NASDAQ:UTHR), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com